Nobel Prize Winner Professor Satoshi Omura, whose discovery of ivermectin led to one of history's greatest public health achievements in transforming the health status of large parts of the globe... gets censored for discussing the science supporting ivermectin in COVID-19. Yup. pic.twitter.com/JHbdZ3nQJm— Pierre Kory, MD MPA (@PierreKory) July 1, 2021
I’m not getting into the grift point, capitalism is grift and at a point that distinction becomes meaningless.
As for cost, That’s a separate problem entirely and goes beyond that too. They make more expensive drugs but they also don’t put money into hard to make drugs for Parkinson’s or Alzheimer’s and then they also don’t make drugs for poor people diseases like malaria. It’s all fucked.
That said, you don’t cure cancer with Benadryl even if someone showed you can kill HeLa cells in a dish with it Moreover, the expensive drugs currently used against covid aren’t just generics plus aspirin, they’re cutting edge medications resulting from a ton of research and a lot of mass scale production troubleshooting. If you really want to solve the problem of fat pharma, stop funding and start investing, taking public stakes in exchange for research and infrastructure grants. That builds oversight and more democratic control. Easier said than done but again you won’t be advancing medicine without making new, expensive innovations.
I’m not getting into the grift point, capitalism is grift and at a point that distinction becomes meaningless.
As for cost, That’s a separate problem entirely and goes beyond that too. They make more expensive drugs but they also don’t put money into hard to make drugs for Parkinson’s or Alzheimer’s and then they also don’t make drugs for poor people diseases like malaria. It’s all fucked.
That said, you don’t cure cancer with Benadryl even if someone showed you can kill HeLa cells in a dish with it Moreover, the expensive drugs currently used against covid aren’t just generics plus aspirin, they’re cutting edge medications resulting from a ton of research and a lot of mass scale production troubleshooting. If you really want to solve the problem of fat pharma, stop funding and start investing, taking public stakes in exchange for research and infrastructure grants. That builds oversight and more democratic control. Easier said than done but again you won’t be advancing medicine without making new, expensive innovations.